BREAST CANCER INTERNATIONAL RESEARCH GROUP

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 551569
                    [Title] => Greater chances of cure for patients with breast cancer
                    [Summary] => 
Roche announced recently its new long-term follow up-data from two large pivotal studies evaluating adjuvant trastuzumab in HER2-positive early- stage breast cancer presented at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). 
                    [DatePublished] => 2010-02-22 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Freeman Cebu Lifestyle
                    [SectionUrl] => cebu-lifestyle
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 294479
                    [Title] => Beating the odds in breast cancer
                    [Summary] => First, the bad news: The Philippines has the highest incidence of breast cancer in Southeast Asia. An estimated 14,000 new cases of breast cancer are expected to occur this year, according to a report by the Philippine Cancer Society. 


Breast cancer is the leading cause of death among Filipino women, and about 6,000 of them are estimated to die from the disease this year.


The good news is that in the last few years there have been exciting developments in the treatment of breast cancer, the most common type of malignancy, next to lung cancer. 


                    [DatePublished] => 2005-09-01 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 246270
                    [Title] => Breast cancer drug boosts survival
                    [Summary] => At least 1,500 lives could be saved every year if a drug used to treat terminal breast cancer cases is given early in the disease.


The Breast Cancer International Research Group (BCIRG) said docetaxel (distributed by Aventis Pharma Inc.) significantly improved the survival rate of women with early-stage breast cancer and reduced their risk of a relapse compared with a standard treatment. This implies that docetaxel is a potential life-saver and should not only be used in terminally ill patients to buy extra time.


                    [DatePublished] => 2004-04-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Greater chances of cure for patients with breast cancer

February 22, 2010 - 12:00am

Roche announced recently its new long-term follow up-data from two large pivotal studies evaluating adjuvant trastuzumab in HER2-positive early- stage breast cancer presented at the CTRC-AACR San Antonio Breast Cancer...

Freeman Cebu Lifestyle

Beating the odds in breast cancer

September 1, 2005 - 12:00am

First, the bad news: The Philippines has the highest incidence of breast cancer in Southeast Asia. An estimated 14,000 new cases of breast cancer are expected to occur this year, according to a report by the Philippine...

Science and Environment

Breast cancer drug boosts survival

April 15, 2004 - 12:00am

At least 1,500 lives could be saved every year if a drug used to treat terminal breast cancer cases is given early in the disease. The Breast Cancer International Research Group (BCIRG) said docetaxel (distributed...

Science and Environment